GlassScriptPhysician profile
Paul L Linsky
NPI 1871818930
$7,970.65
in general payments reported to CMS, 2019-2025
13 companies · $4,927 in 2025
The $4,927 reported for 2025 was more than what 82% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $164 · 2021: $394 · 2023: $534 · 2024: $1,258 · 2025: $4,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520 · Education: $2,500 · Travel and Lodging: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,520.37 |
| Education | $2,500.00 |
| Travel and Lodging | $1,698.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,977.83 | 2019-2025 | Da Vinci Surgical System |
| Atricure, INC. | $1,168.13 | 2019-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Baxter Healthcare | $368.95 | 2023-2025 | Preveleak, Perclot |
| On Target Laboratories, INC | $226.92 | 2025 | Cytalux |
| Edwards Lifesciences Corporation | $203.73 | 2025 | Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $156.30 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $152.08 | 2021-2023 | |
| Boston Scientific Corporation | $146.11 | 2019-2021 | |
| Genentech USA, INC. | $142.58 | 2023 | Tecentriq |
| Medtronic, INC. | $140.54 | 2023-2025 | Signia |
| Pulmonx Corporation | $127.77 | 2019 | |
| Tempus Ai, INC | $110.01 | 2025 | Xt Cdx |
| Pinnacle Biologics, INC | $49.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Linsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.